Solamargine inhibits gastric cancer progression by regulating the expression of lncNEAT1_2 via the MAPK signaling pathway

Solamargine, a derivative from the steroidal solasodine in Solanum species, has exhibited anticancer activities in numerous types of cancer; however, its role in gastric cancer (GC) remains unknown. In the present study, it was demonstrated that Solamargine suppressed the viability of five gastric cancer cell lines in a dose-dependent manner and induced notable alterations in morphology. Treatment with Solamargine promoted cell apoptosis (P<0.01). Solamargine increased the expression of long noncoding RNA (lnc) p53 induced transcript and lnc nuclear paraspeckle assembly transcript 1 (NEAT1)_2 (P<0.01) in GC by reducing the phosphorylation of extracellular signal-regulated kinase (Erk)1/2 mitogen-activated protein kinase (MAPK). To gain insight into the potential mechanism, an Erk1/2 inhibitor (U0126) was applied. The results revealed that lncNEAT1_2 expression levels increased, which was consistent with the effects of Solamargine. Downregulation of lncNEAT1_2 in GC cells revealed no effect on the expression levels of total Erk1/2 and, and counteracted the effect of Solamargine. Solamargine was observed to increase the expression of lncNEAT1_2 via the Erk1/2 MAPK signaling pathway. Of note, the knockdown of lncNEAT1_2 reduced the inhibitory effect of Solamargine (P<0.05). Additionally, experiments in vivo and in primary GC cells from patients demonstrated that Solamargine significantly suppressed tumor growth (P<0.05). In vivo analysis of a xenograft mouse model further supported that Solamargine could induce the apoptosis of cancer cells in tumor tissue as observed by a terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick end labeling and H&E staining (P<0.05). Experiments in primary GC cells from patients verified the anti-tumor effect of Solamargine. In summary, the findings of the present study indicated that Solamargine inhibited the progression of GC by regulating lncNeat1_2 via the MAPK pathway.

[1]  Hong Zhang,et al.  Long noncoding RNA NEAT1 regulate papillary thyroid cancer progression by modulating miR‐129‐5p/KLK7 expression , 2018, Journal of cellular physiology.

[2]  Haimin Li,et al.  PTBP3 splicing factor promotes hepatocellular carcinoma by destroying the splicing balance of NEAT1 and pre-miR-612 , 2018, Oncogene.

[3]  P. Steenkamp,et al.  Solamargine, a bioactive steroidal alkaloid isolated from Solanum aculeastrum induces non-selective cytotoxicity and P-glycoprotein inhibition , 2018, BMC Complementary and Alternative Medicine.

[4]  S. Agarwal,et al.  Patient-derived conditionally reprogrammed cells maintain intra-tumor genetic heterogeneity , 2018, Scientific Reports.

[5]  I. Ulitsky,et al.  The human lncRNA LINC-PINT inhibits tumor cell invasion through a highly conserved sequence element , 2017, Genome Biology.

[6]  Rui Zhang,et al.  Long non-coding RNA XIST regulates PDCD4 expression by interacting with miR-21-5p and inhibits osteosarcoma cell growth and metastasis , 2017, International journal of oncology.

[7]  N. S. Yarla,et al.  MAPK signalling pathway in cancers: Olive products as cancer preventive and therapeutic agents. , 2017, Seminars in cancer biology.

[8]  Hong-yan Liu,et al.  Modulation of IGF2BP1 by long non-coding RNA HCG11 suppresses apoptosis of hepatocellular carcinoma cells via MAPK signaling transduction , 2017, International journal of oncology.

[9]  Haitao Zhu,et al.  Solamargine inhibits the migration and invasion of HepG2 cells by blocking epithelial-to-mesenchymal transition. , 2017, Oncology letters.

[10]  F. Kalalinia,et al.  Anticancer Properties of Solamargine: A Systematic Review , 2017, Phytotherapy research : PTR.

[11]  J. Rinn,et al.  Neat1 is a p53-inducible lincRNA essential for transformation suppression , 2017, Genes & development.

[12]  O. Julien,et al.  Caspases and their substrates , 2017, Cell Death and Differentiation.

[13]  Xia Li,et al.  The long non-coding RNA lncFOXO1 suppresses growth of human breast cancer cells through association with BAP1. , 2017, International journal of oncology.

[14]  W. Wu,et al.  NEAT1: A novel cancer‐related long non‐coding RNA , 2017, Cell proliferation.

[15]  N. Blüthgen,et al.  Profiling the MAPK/ERK dependent and independent activity regulated transcriptional programs in the murine hippocampus in vivo , 2017, Scientific Reports.

[16]  F. Zheng,et al.  Activation of AMPKα mediates additive effects of solamargine and metformin on suppressing MUC1 expression in castration-resistant prostate cancer cells , 2016, Scientific Reports.

[17]  G. Wang,et al.  Plasma and tumor levels of Linc-pint are diagnostic and prognostic biomarkers for pancreatic cancer , 2016, Oncotarget.

[18]  Qing Tang,et al.  Targeting EP4 downstream c‐Jun through ERK1/2‐mediated reduction of DNMT1 reveals novel mechanism of solamargine‐inhibited growth of lung cancer cells , 2016, Journal of cellular and molecular medicine.

[19]  Yung-Hyun Choi,et al.  Baicalein induces apoptosis via ROS-dependent activation of caspases in human bladder cancer 5637 cells. , 2016, International journal of oncology.

[20]  Shanshan Wang,et al.  The role of MAPK signaling pathway in the Her-2-positive meningiomas , 2016, Oncology reports.

[21]  G. Shan,et al.  Functions of long noncoding RNAs in the nucleus , 2016, Nucleus.

[22]  Howard Y. Chang,et al.  Long Noncoding RNAs in Cancer Pathways. , 2016, Cancer cell.

[23]  B. Coomber,et al.  Solamargine triggers cellular necrosis selectively in different types of human melanoma cancer cells through extrinsic lysosomal mitochondrial death pathway , 2016, Cancer Cell International.

[24]  F. Zheng,et al.  Inactivation of PI3-K/Akt and reduction of SP1 and p65 expression increase the effect of solamargine on suppressing EP4 expression in human lung cancer cells , 2015, Journal of Experimental & Clinical Cancer Research.

[25]  Ye Xu,et al.  Nuclear-enriched abundant transcript 1 as a diagnostic and prognostic biomarker in colorectal cancer , 2015, Molecular Cancer.

[26]  Tzu-Hao Chang,et al.  Solanum Incanum Extract Downregulates Aldehyde Dehydrogenase 1-Mediated Stemness and Inhibits Tumor Formation in Ovarian Cancer Cells , 2015, Journal of Cancer.

[27]  Ying Wang,et al.  Solamargine triggers hepatoma cell death through apoptosis. , 2015, Oncology letters.

[28]  A. Jemal,et al.  Global cancer statistics, 2012 , 2015, CA: a cancer journal for clinicians.

[29]  J. Xie,et al.  ABCG2 regulated by MAPK pathways is associated with cancer progression in laryngeal squamous cell carcinoma. , 2014, American journal of cancer research.

[30]  Qing Tang,et al.  Targeting signal transducer and activator of transcription 3 contributes to the solamargine-inhibited growth and -induced apoptosis of human lung cancer cells , 2014, Tumor Biology.

[31]  Douglas J. Chapski,et al.  The mTORC1 Pathway Stimulates Glutamine Metabolism and Cell Proliferation by Repressing SIRT4 , 2013, Cell.

[32]  Joseph Avruch,et al.  Mammalian MAPK signal transduction pathways activated by stress and inflammation: a 10-year update. , 2012, Physiological reviews.

[33]  Fangshi Zhu,et al.  Induction of apoptosis in human hepatoma SMMC-7721 cells by solamargine from Solanum nigrum L. , 2012, Journal of ethnopharmacology.

[34]  Bin Sun,et al.  Synthesis of solasodine glycoside derivatives and evaluation of their cytotoxic effects on human cancer cells. , 2012, Drug discoveries & therapeutics.

[35]  Haiyang Xie,et al.  Involvement of ERK and JNK pathways in IFN-γ-induced B7-DC expression on tumor cells , 2011, Journal of Cancer Research and Clinical Oncology.

[36]  Huiqing Yuan,et al.  A lysosomal-mitochondrial death pathway is induced by solamargine in human K562 leukemia cells. , 2010, Toxicology in vitro : an international journal published in association with BIBRA.

[37]  K. Kuo,et al.  Solamargine induces apoptosis and sensitizes breast cancer cells to cisplatin. , 2007, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[38]  X. Coumoul,et al.  RNA interference and inhibition of MEK-ERK signaling prevent abnormal skeletal phenotypes in a mouse model of craniosynostosis , 2007, Nature Genetics.

[39]  D. Morrison,et al.  Regulation of MAP kinase signaling modules by scaffold proteins in mammals. , 2003, Annual review of cell and developmental biology.

[40]  D. Trisciuoglio,et al.  Bcl-2 has differing effects on the sensitivity of breast cancer cells depending on the antineoplastic drug used. , 2002, European Journal of Cancer.

[41]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[42]  J. Lord,et al.  Serine/threonine protein kinases and apoptosis. , 2000, Experimental cell research.

[43]  M. Claesson,et al.  MHC-I-induced apoptosis in human B-lymphoma cells is dependent on protein tyrosine and serine/threonine kinases. , 1999, Experimental cell research.

[44]  K. Kuo,et al.  Solamargine purified from Solanum incanum Chinese herb triggers gene expression of human TNFR I which may lead to cell apoptosis. , 1996, Biochemical and biophysical research communications.

[45]  Andrew N. Rowan.  Guide for the Care and Use of Laboratory Animals , 1996 .

[46]  W. P. Norred,et al.  Pharmacology and toxicology of chaconine and tomatine. , 1975, Research communications in chemical pathology and pharmacology.

[47]  A. Jemal,et al.  Cancer statistics, 2017 , 2017, CA: a cancer journal for clinicians.

[48]  T. Ushijima,et al.  Integrated analysis of cancer-related pathways affected by genetic and epigenetic alterations in gastric cancer , 2014, Gastric Cancer.

[49]  A. Jemal,et al.  Global cancer statistics , 2011, CA: a cancer journal for clinicians.